MDA-MB-453
MDA-MB-453 was derived in 1976 by R. Cailleau et al. From an effusion of a 48 year old female patient with metastatic carcinoma of the breast, involving the nodes, brain and both pleural and pericardial cavities. The cells overexpress FGF receptors.
Product Specifications
Applications
For research use only
Storage Conditions
Liquid Nitrogen
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
OR1064617-01 100 mg
(S) -tert-Butyl 3- (((benzyloxy) carbonyl) amino) -4-hydroxybutanoate
Sign In for Pricing
View Details OR1064617-02 250 mg
(S) -tert-Butyl 3- (((benzyloxy) carbonyl) amino) -4-hydroxybutanoate
Sign In for Pricing
View Details OR1064617-03 1 g
(S) -tert-Butyl 3- (((benzyloxy) carbonyl) amino) -4-hydroxybutanoate
Sign In for Pricing
View Details 